rxstat › Classes › Anxiolytics
Anxiolytics: shortage status in Canada
7 of the 9 anxiolytics rxstat tracks are currently in shortage in Canada. When one drug in a class is short, demand often shifts to its alternatives, so related drugs can tighten too; each page below shows which manufacturers are affected and the latest recovery estimates.
Widespread shortageBuspirone5 of 8 reported products affected · est. return Aug 3, 2026Widespread shortageChlordiazepoxide2 of 3 reported products affectedWidespread shortageOxazepam6 of 10 reported products affectedPartial shortageAlprazolam4 of 20 reported products affected · est. return Jul 3, 2026Partial shortageDiazepam4 of 18 reported products affectedPartial shortageHydroxyzine2 of 8 reported products affectedPartial shortageLorazepam1 of 27 reported products affected · est. return May 1, 2026No current shortageBromazepamNo current shortageClobazam
Class groupings follow the WHO ATC classification in Health Canada's reports. Data reflects manufacturer mandatory filings; see methodology.